Form 483

Temmentech AG Form 483, 2016-06-17

FDA issued a Form 483 to Temmentech AG on 2016-06-17 with 12 public-safe observations.

483· Form 483 issuedHuman Drugs12 observations

Temmentech AG · Sumiswald, Switzerland · Issued June 17, 2016

Overview

  • 12 public-safe observations are available for this inspection.
  • 12 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

17 Jun 2016
21 CFR 211.67(a)

Cleaning / Sanitizing / Maintenance

Cited by Massoud Motamed

17 Jun 2016
21 CFR 211.68(b)

Computer control of master formula records

Cited by Massoud Motamed

17 Jun 2016
21 CFR 211.110(a)

Control procedures to monitor and validate performance

Cited by Massoud Motamed

17 Jun 2016
21 CFR 211.137(a)

Expiration date lacking

Cited by Massoud Motamed

17 Jun 2016
21 CFR 211.165(e)

Test methods

Cited by Massoud Motamed

Inspected site

TATemmentech AGSumiswald, Switzerland

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
21 CFR 211.137(a)Cited across public-safe Form 483 observations1x
21 CFR 211.165(e)Cited across public-safe Form 483 observations1x
21 CFR 211.165(f)Cited across public-safe Form 483 observations1x
21 CFR 211.180(e)(2)Cited across public-safe Form 483 observations1x
21 CFR 211.186(b)(9)Cited across public-safe Form 483 observations1x
21 CFR 211.188(a)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x
21 CFR 211.80(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 12 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere